NVUS insider filings

Eledon Pharmaceuticals, Inc. — 8 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2020-12-28. Screen NVUS transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for NVUS between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Eledon Pharmaceuticals, Inc.

FiledFormInsiderReported transactionsSource
2020-12-284BVF PARTNERS L P/IL
BIOTECHNOLOGY VALUE FUND L P
BVF I GP LLC
BIOTECHNOLOGY VALUE FUND II LP
BVF II GP LLC
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF GP HOLDINGS LLC
BVF INC/IL
LAMPERT MARK N
Conversion (C): 15,166 · Conversion (C): 654,215 · Conversion (C): 11,278 · Conversion (C): 509,410 · Conversion (C): 1,944 · Conversion (C): 97,615 · +6 moreEDGAR
2020-12-044OrbiMed Israel GP Ltd. — 10% owner
OrbiMed Israel BioFund GP Limited Partnership — 10% owner
Sale (S): 103,200 @ $21.60EDGAR
2020-11-064Logos Global Management LP — 10% ownerPurchase (P): 5,000 @ $24.03 · Purchase (P): 31,000 @ $24.53 · Purchase (P): 4,000 @ $25.97 · Purchase (P): 15,000 @ $26.48 · Sale (S): 12,942 @ $26.64 · Purchase (P): 12,942 @ $25.88 · +3 moreEDGAR
2020-09-154Kuwahara Jon — See RemarksGrant/award (A): 2,145.26 (derivative) @ $0EDGAR
2020-09-154Gros David-Alexandre C — Chief Executive Officer, DirectorGrant/award (A): 18,278.14 (derivative) @ $0EDGAR
2020-09-154McBride John S. — DirectorGrant/award (A): 1,167.21 (derivative) @ $0EDGAR
2020-09-154Katkin Keith — DirectorGrant/award (A): 5,907.15 (derivative) @ $0EDGAR
2020-09-154LYONS GARY A — DirectorGrant/award (A): 1,167.21 (derivative) @ $0EDGAR

Recent 8-K events — Eledon Pharmaceuticals, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-228-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-198-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-028-K3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-138-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-078-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-08-148-K2.02 — Results of Operations and Financial Condition
4.02 — Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=NVUS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs